Search

Valeant to sell Obagi skin-care business for US$190M

LAVAL, Que. - Valeant Pharmaceuticals International, Inc. (TSX:VRX) has a deal to sell its Obagi skin care business to a Hong Kong-based group for US$190 million in cash.

The Quebec-based company, headquartered in Laval, estimates its Obagi Medical Products unit will generate about US$85 million of revenue in 2017.

The buyer is a fund managed by a limited partnership that includes China Regenerative Medicine International and Haitong International Securities Group, both headquartered in Hong Kong.

Let's block ads! (Why?)



Bagikan Berita Ini

Related Posts :

0 Response to "Valeant to sell Obagi skin-care business for US$190M"

Post a Comment

Powered by Blogger.